Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO32471 | Aspergillus sp. | Species | Aspergillaceae | Eukaryota |
PMID[11809055] |
|||
NPO32737 | mitosporic dothideomycete sp. lrub20 | Species | NA | NA |
PMID[16989533] |
|||
NPO21233 | Pteris linearis | Species | Pteridaceae | Eukaryota | UNPD* | |||
NPO15947 | Penicillium glabrum | Species | Aspergillaceae | Eukaryota | UNPD* | |||
NPO10938 | Psychotria prunifolia | Species | Rubiaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT3951 | Individual Protein | Endothelin receptor ET-A | Rattus norvegicus | IC50 | = | 10000 | nM | 11809055 |
NPT530 | Organism | Caenorhabditis elegans | Caenorhabditis elegans | LD90 | = | 50 | ppm | 11809055 |
NPT88 | Organism | Mycobacterium tuberculosis | Mycobacterium tuberculosis | MIC | = | 200 | ug/ml | 16989533 |
NPT44 | Individual Protein | Bifunctional protein glmU | Mycobacterium tuberculosis | IC50 | = | 82700 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 11668.1 | nM | PubChem BioAssay data set |
NPT2796 | Individual Protein | Apoptosis regulator Bcl-X | Homo sapiens | IC50 | = | 54218 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 17782.8 | nM | PubChem BioAssay data set |
NPT52 | Individual Protein | Pyruvate kinase isozymes M1/M2 | Homo sapiens | Potency | = | 3981.1 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 7079.5 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 11582.1 | nM | PubChem BioAssay data set | |
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 7079.5 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 56234.1 | nM | PubChem BioAssay data set |
NPT57 | Individual Protein | Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens | IC50 | = | 5478 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 15811.4 | nM | PubChem BioAssay data set |
NPT57 | Individual Protein | Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens | IC50 | = | 2419.77 | nM | PubChem BioAssay data set |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 281.8 | nM | PubChem BioAssay data set |
NPT58 | Individual Protein | Bloom syndrome protein | Homo sapiens | Potency | = | 8912.5 | nM | PubChem BioAssay data set |
NPT59 | Individual Protein | DNA polymerase beta | Homo sapiens | Potency | = | 3162.3 | nM | PubChem BioAssay data set |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 163.6 | nM | PubChem BioAssay data set | |
NPT4214 | Protein Complex | SUMO-activating enzyme | Homo sapiens | IC50 | = | 17680 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 2238.7 | nM | PubChem BioAssay data set | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 8912.5 | nM | PubChem BioAssay data set | |
NPT4214 | Protein Complex | SUMO-activating enzyme | Homo sapiens | IC50 | = | 7420 | nM | PubChem BioAssay data set |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 29081 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 100000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 125892.5 | nM | PubChem BioAssay data set | ||
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | 5011.9 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT1397 | Cell Line | INS1 | Rattus norvegicus | AC50 | = | 8126 | nM | PubChem BioAssay data set |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 3548.1 | nM | PubChem BioAssay data set | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 891.3 | nM | PubChem BioAssay data set | ||
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 5623.4 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 2616.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | > | 67543 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 20687 | nM | PubChem BioAssay data set | |
NPT534 | Individual Protein | Phosphoglycerate kinase, glycosomal | Trypanosoma brucei brucei | Potency | 7079.5 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 29092.9 | nM | PubChem BioAssay data set | |
NPT2799 | Individual Protein | Small ubiquitin-related modifier 1 | Homo sapiens | IC50 | 66600 | nM | PubChem BioAssay data set | |
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 8912.5 | nM | PubChem BioAssay data set | |
NPT821 | Individual Protein | Werner syndrome ATP-dependent helicase | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT2799 | Individual Protein | Small ubiquitin-related modifier 1 | Homo sapiens | IC50 | 8120 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1032.3 | nM | PubChem BioAssay data set | ||
NPT1854 | Individual Protein | Phosphoglycerate kinase | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | Potency | 1031.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1158.2 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 23109.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | PubChem BioAssay data set | ||
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 11995.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | 4574 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | PubChem BioAssay data set | ||
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | 2587 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 631 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 75686.3 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 13371.4 | nM | PubChem BioAssay data set | |
NPT446 | Individual Protein | Rap guanine nucleotide exchange factor 3 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | > | 2000 | nM | 26706176 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC106334 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC285527 |
0.993 | High Similarity | NPC164527 |
0.993 | High Similarity | NPC213382 |
0.9521 | High Similarity | NPC225129 |
0.9467 | High Similarity | NPC287458 |
0.9404 | High Similarity | NPC98892 |
0.9262 | High Similarity | NPC289968 |
0.9133 | High Similarity | NPC75069 |
0.9054 | High Similarity | NPC46941 |
0.9026 | High Similarity | NPC130955 |
0.9013 | High Similarity | NPC208197 |
0.8987 | High Similarity | NPC49487 |
0.8987 | High Similarity | NPC99613 |
0.8974 | High Similarity | NPC300984 |
0.8968 | High Similarity | NPC217950 |
0.8954 | High Similarity | NPC54928 |
0.8947 | High Similarity | NPC250822 |
0.8947 | High Similarity | NPC472915 |
0.8947 | High Similarity | NPC276409 |
0.8947 | High Similarity | NPC75279 |
0.8947 | High Similarity | NPC280937 |
0.894 | High Similarity | NPC208043 |
0.894 | High Similarity | NPC226973 |
0.894 | High Similarity | NPC308451 |
0.8933 | High Similarity | NPC294502 |
0.8933 | High Similarity | NPC200221 |
0.8933 | High Similarity | NPC328119 |
0.8931 | High Similarity | NPC109827 |
0.8931 | High Similarity | NPC124470 |
0.8931 | High Similarity | NPC72696 |
0.8926 | High Similarity | NPC93034 |
0.8926 | High Similarity | NPC119660 |
0.8889 | High Similarity | NPC196439 |
0.8889 | High Similarity | NPC20830 |
0.8889 | High Similarity | NPC256612 |
0.8889 | High Similarity | NPC2476 |
0.8889 | High Similarity | NPC167815 |
0.8889 | High Similarity | NPC138360 |
0.8889 | High Similarity | NPC280339 |
0.8889 | High Similarity | NPC128863 |
0.8889 | High Similarity | NPC183597 |
0.8889 | High Similarity | NPC163780 |
0.8889 | High Similarity | NPC4455 |
0.8889 | High Similarity | NPC146165 |
0.8889 | High Similarity | NPC201136 |
0.8889 | High Similarity | NPC50715 |
0.8889 | High Similarity | NPC471800 |
0.8889 | High Similarity | NPC92659 |
0.8889 | High Similarity | NPC227325 |
0.8882 | High Similarity | NPC199773 |
0.8875 | High Similarity | NPC158226 |
0.8875 | High Similarity | NPC188618 |
0.8874 | High Similarity | NPC306821 |
0.8874 | High Similarity | NPC179183 |
0.8861 | High Similarity | NPC20216 |
0.8861 | High Similarity | NPC29160 |
0.8854 | High Similarity | NPC474350 |
0.8854 | High Similarity | NPC156082 |
0.8846 | High Similarity | NPC303565 |
0.8844 | High Similarity | NPC124467 |
0.8844 | High Similarity | NPC214919 |
0.8839 | High Similarity | NPC238381 |
0.8839 | High Similarity | NPC154304 |
0.8839 | High Similarity | NPC190487 |
0.8839 | High Similarity | NPC83763 |
0.8839 | High Similarity | NPC168616 |
0.8831 | High Similarity | NPC472916 |
0.8831 | High Similarity | NPC474520 |
0.8831 | High Similarity | NPC178854 |
0.8824 | High Similarity | NPC160951 |
0.8824 | High Similarity | NPC183878 |
0.8824 | High Similarity | NPC274327 |
0.8824 | High Similarity | NPC22519 |
0.8824 | High Similarity | NPC298802 |
0.8824 | High Similarity | NPC145379 |
0.8824 | High Similarity | NPC86485 |
0.8824 | High Similarity | NPC471981 |
0.8824 | High Similarity | NPC176775 |
0.8824 | High Similarity | NPC69394 |
0.8824 | High Similarity | NPC231018 |
0.8824 | High Similarity | NPC246204 |
0.8824 | High Similarity | NPC47781 |
0.8824 | High Similarity | NPC475895 |
0.8824 | High Similarity | NPC255350 |
0.882 | High Similarity | NPC181523 |
0.8816 | High Similarity | NPC117579 |
0.8816 | High Similarity | NPC149614 |
0.8816 | High Similarity | NPC474663 |
0.8812 | High Similarity | NPC10576 |
0.8812 | High Similarity | NPC17219 |
0.8812 | High Similarity | NPC246716 |
0.8808 | High Similarity | NPC92722 |
0.8808 | High Similarity | NPC102003 |
0.8805 | High Similarity | NPC234331 |
0.88 | High Similarity | NPC62536 |
0.88 | High Similarity | NPC33265 |
0.8797 | High Similarity | NPC267153 |
0.8797 | High Similarity | NPC112981 |
0.879 | High Similarity | NPC93739 |
0.8782 | High Similarity | NPC188967 |
0.8774 | High Similarity | NPC78302 |
0.8774 | High Similarity | NPC224137 |
0.8774 | High Similarity | NPC75215 |
0.8774 | High Similarity | NPC29841 |
0.8774 | High Similarity | NPC235215 |
0.8774 | High Similarity | NPC7973 |
0.8774 | High Similarity | NPC93376 |
0.8774 | High Similarity | NPC476981 |
0.8774 | High Similarity | NPC181960 |
0.8774 | High Similarity | NPC227192 |
0.8774 | High Similarity | NPC472438 |
0.8774 | High Similarity | NPC262286 |
0.8774 | High Similarity | NPC36852 |
0.8774 | High Similarity | NPC189179 |
0.8766 | High Similarity | NPC37392 |
0.8766 | High Similarity | NPC286052 |
0.8766 | High Similarity | NPC32557 |
0.8766 | High Similarity | NPC472909 |
0.8766 | High Similarity | NPC189960 |
0.8766 | High Similarity | NPC213622 |
0.8766 | High Similarity | NPC2928 |
0.8758 | High Similarity | NPC241498 |
0.8758 | High Similarity | NPC60972 |
0.8758 | High Similarity | NPC275722 |
0.8758 | High Similarity | NPC256283 |
0.8758 | High Similarity | NPC188203 |
0.8758 | High Similarity | NPC83508 |
0.8758 | High Similarity | NPC275836 |
0.8758 | High Similarity | NPC131624 |
0.8758 | High Similarity | NPC39732 |
0.8758 | High Similarity | NPC57030 |
0.8758 | High Similarity | NPC101996 |
0.8758 | High Similarity | NPC120163 |
0.8758 | High Similarity | NPC198826 |
0.8758 | High Similarity | NPC212678 |
0.8758 | High Similarity | NPC134677 |
0.8758 | High Similarity | NPC142540 |
0.8758 | High Similarity | NPC25270 |
0.8758 | High Similarity | NPC100887 |
0.8758 | High Similarity | NPC156222 |
0.8758 | High Similarity | NPC239128 |
0.8758 | High Similarity | NPC301323 |
0.8758 | High Similarity | NPC222830 |
0.8758 | High Similarity | NPC293183 |
0.8758 | High Similarity | NPC187498 |
0.8758 | High Similarity | NPC162313 |
0.8758 | High Similarity | NPC71334 |
0.8758 | High Similarity | NPC301123 |
0.875 | High Similarity | NPC239363 |
0.875 | High Similarity | NPC219330 |
0.875 | High Similarity | NPC165979 |
0.875 | High Similarity | NPC476279 |
0.875 | High Similarity | NPC163130 |
0.875 | High Similarity | NPC29056 |
0.875 | High Similarity | NPC280493 |
0.875 | High Similarity | NPC26568 |
0.8742 | High Similarity | NPC15329 |
0.8742 | High Similarity | NPC55327 |
0.8742 | High Similarity | NPC107636 |
0.8742 | High Similarity | NPC195202 |
0.8742 | High Similarity | NPC131451 |
0.8734 | High Similarity | NPC477689 |
0.8734 | High Similarity | NPC284007 |
0.8733 | High Similarity | NPC302408 |
0.8733 | High Similarity | NPC209278 |
0.8733 | High Similarity | NPC283002 |
0.8726 | High Similarity | NPC66288 |
0.8725 | High Similarity | NPC23955 |
0.8718 | High Similarity | NPC300943 |
0.8718 | High Similarity | NPC143828 |
0.8718 | High Similarity | NPC115798 |
0.8718 | High Similarity | NPC288669 |
0.8718 | High Similarity | NPC193842 |
0.8718 | High Similarity | NPC19687 |
0.8718 | High Similarity | NPC25495 |
0.8718 | High Similarity | NPC261004 |
0.8718 | High Similarity | NPC18772 |
0.8718 | High Similarity | NPC195832 |
0.8718 | High Similarity | NPC4481 |
0.8718 | High Similarity | NPC152166 |
0.8718 | High Similarity | NPC18607 |
0.8718 | High Similarity | NPC176300 |
0.8718 | High Similarity | NPC253634 |
0.8718 | High Similarity | NPC22472 |
0.8718 | High Similarity | NPC105242 |
0.8718 | High Similarity | NPC45846 |
0.8718 | High Similarity | NPC204854 |
0.8718 | High Similarity | NPC9609 |
0.8718 | High Similarity | NPC191459 |
0.8718 | High Similarity | NPC130894 |
0.8718 | High Similarity | NPC7846 |
0.871 | High Similarity | NPC100916 |
0.871 | High Similarity | NPC55619 |
0.871 | High Similarity | NPC472453 |
0.871 | High Similarity | NPC247017 |
0.871 | High Similarity | NPC98661 |
0.871 | High Similarity | NPC200388 |
0.871 | High Similarity | NPC268161 |
0.871 | High Similarity | NPC138243 |
0.871 | High Similarity | NPC45131 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC106334 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8824 | High Similarity | NPD2801 | Approved |
0.863 | High Similarity | NPD1551 | Phase 2 |
0.8611 | High Similarity | NPD447 | Suspended |
0.8553 | High Similarity | NPD6232 | Discontinued |
0.8526 | High Similarity | NPD3817 | Phase 2 |
0.8526 | High Similarity | NPD5402 | Approved |
0.8471 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8471 | Intermediate Similarity | NPD3882 | Suspended |
0.8397 | Intermediate Similarity | NPD1934 | Approved |
0.8395 | Intermediate Similarity | NPD7473 | Discontinued |
0.8313 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8293 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8255 | Intermediate Similarity | NPD2935 | Discontinued |
0.8235 | Intermediate Similarity | NPD1511 | Approved |
0.8232 | Intermediate Similarity | NPD3818 | Discontinued |
0.8228 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8129 | Intermediate Similarity | NPD1512 | Approved |
0.8117 | Intermediate Similarity | NPD6799 | Approved |
0.8113 | Intermediate Similarity | NPD1465 | Phase 2 |
0.811 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.811 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.811 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8108 | Intermediate Similarity | NPD1933 | Approved |
0.8086 | Intermediate Similarity | NPD5494 | Approved |
0.8077 | Intermediate Similarity | NPD5403 | Approved |
0.8075 | Intermediate Similarity | NPD7075 | Discontinued |
0.8072 | Intermediate Similarity | NPD7054 | Approved |
0.8056 | Intermediate Similarity | NPD1203 | Approved |
0.8038 | Intermediate Similarity | NPD6599 | Discontinued |
0.8026 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8024 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8024 | Intermediate Similarity | NPD7472 | Approved |
0.8 | Intermediate Similarity | NPD7819 | Suspended |
0.7987 | Intermediate Similarity | NPD230 | Phase 1 |
0.7975 | Intermediate Similarity | NPD3226 | Approved |
0.7949 | Intermediate Similarity | NPD2534 | Approved |
0.7949 | Intermediate Similarity | NPD2532 | Approved |
0.7949 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7949 | Intermediate Similarity | NPD5401 | Approved |
0.7949 | Intermediate Similarity | NPD2533 | Approved |
0.7933 | Intermediate Similarity | NPD1607 | Approved |
0.7929 | Intermediate Similarity | NPD6559 | Discontinued |
0.7922 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7922 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7905 | Intermediate Similarity | NPD411 | Approved |
0.7891 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7888 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7882 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7875 | Intermediate Similarity | NPD7411 | Suspended |
0.787 | Intermediate Similarity | NPD6797 | Phase 2 |
0.787 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7867 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7853 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7847 | Intermediate Similarity | NPD9717 | Approved |
0.7843 | Intermediate Similarity | NPD2346 | Discontinued |
0.7826 | Intermediate Similarity | NPD6801 | Discontinued |
0.7824 | Intermediate Similarity | NPD7251 | Discontinued |
0.7812 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7806 | Intermediate Similarity | NPD3750 | Approved |
0.78 | Intermediate Similarity | NPD1240 | Approved |
0.7799 | Intermediate Similarity | NPD1653 | Approved |
0.7792 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7791 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7736 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7727 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7727 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7725 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7722 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7716 | Intermediate Similarity | NPD37 | Approved |
0.7714 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7712 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7711 | Intermediate Similarity | NPD1247 | Approved |
0.7711 | Intermediate Similarity | NPD6959 | Discontinued |
0.7697 | Intermediate Similarity | NPD919 | Approved |
0.7697 | Intermediate Similarity | NPD6234 | Discontinued |
0.7692 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7683 | Intermediate Similarity | NPD4965 | Approved |
0.7683 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7683 | Intermediate Similarity | NPD4966 | Approved |
0.7667 | Intermediate Similarity | NPD2313 | Discontinued |
0.7667 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7662 | Intermediate Similarity | NPD2796 | Approved |
0.7597 | Intermediate Similarity | NPD2799 | Discontinued |
0.7597 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7574 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7566 | Intermediate Similarity | NPD943 | Approved |
0.7532 | Intermediate Similarity | NPD6190 | Approved |
0.753 | Intermediate Similarity | NPD3749 | Approved |
0.7529 | Intermediate Similarity | NPD8313 | Approved |
0.7529 | Intermediate Similarity | NPD8312 | Approved |
0.7528 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7515 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7484 | Intermediate Similarity | NPD3748 | Approved |
0.7483 | Intermediate Similarity | NPD9493 | Approved |
0.7467 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7457 | Intermediate Similarity | NPD5953 | Discontinued |
0.7442 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7438 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7436 | Intermediate Similarity | NPD6100 | Approved |
0.7436 | Intermediate Similarity | NPD6099 | Approved |
0.7417 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.741 | Intermediate Similarity | NPD5353 | Approved |
0.7407 | Intermediate Similarity | NPD920 | Approved |
0.7405 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7405 | Intermediate Similarity | NPD1243 | Approved |
0.7405 | Intermediate Similarity | NPD2800 | Approved |
0.74 | Intermediate Similarity | NPD1019 | Discontinued |
0.7396 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7384 | Intermediate Similarity | NPD7228 | Approved |
0.7368 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7365 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7353 | Intermediate Similarity | NPD5711 | Approved |
0.7353 | Intermediate Similarity | NPD5710 | Approved |
0.7341 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7338 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7338 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7338 | Intermediate Similarity | NPD1613 | Approved |
0.7333 | Intermediate Similarity | NPD2797 | Approved |
0.7329 | Intermediate Similarity | NPD9268 | Approved |
0.7317 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7315 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.731 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.731 | Intermediate Similarity | NPD5242 | Approved |
0.7297 | Intermediate Similarity | NPD422 | Phase 1 |
0.7284 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7284 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7279 | Intermediate Similarity | NPD1778 | Approved |
0.7267 | Intermediate Similarity | NPD3225 | Approved |
0.7261 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7248 | Intermediate Similarity | NPD1608 | Approved |
0.7247 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7237 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7237 | Intermediate Similarity | NPD9494 | Approved |
0.723 | Intermediate Similarity | NPD3496 | Discontinued |
0.7229 | Intermediate Similarity | NPD6385 | Approved |
0.7229 | Intermediate Similarity | NPD6386 | Approved |
0.7222 | Intermediate Similarity | NPD4357 | Discontinued |
0.7216 | Intermediate Similarity | NPD7039 | Approved |
0.7216 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7216 | Intermediate Similarity | NPD7038 | Approved |
0.7208 | Intermediate Similarity | NPD3268 | Approved |
0.7208 | Intermediate Similarity | NPD1699 | Clinical (unspecified phase) |
0.7207 | Intermediate Similarity | NPD8150 | Discontinued |
0.7207 | Intermediate Similarity | NPD8434 | Phase 2 |
0.72 | Intermediate Similarity | NPD4749 | Approved |
0.7186 | Intermediate Similarity | NPD6844 | Discontinued |
0.7184 | Intermediate Similarity | NPD3751 | Discontinued |
0.7171 | Intermediate Similarity | NPD2798 | Approved |
0.717 | Intermediate Similarity | NPD2344 | Approved |
0.7168 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7161 | Intermediate Similarity | NPD6233 | Phase 2 |
0.716 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD7033 | Discontinued |
0.7152 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7151 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7134 | Intermediate Similarity | NPD6651 | Approved |
0.7134 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7133 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7128 | Intermediate Similarity | NPD7435 | Discontinued |
0.7117 | Intermediate Similarity | NPD7390 | Discontinued |
0.7107 | Intermediate Similarity | NPD5408 | Approved |
0.7107 | Intermediate Similarity | NPD5405 | Approved |
0.7107 | Intermediate Similarity | NPD5404 | Approved |
0.7107 | Intermediate Similarity | NPD5406 | Approved |
0.7093 | Intermediate Similarity | NPD8127 | Discontinued |
0.7086 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7086 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7079 | Intermediate Similarity | NPD7549 | Discontinued |
0.7075 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7073 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7067 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7067 | Intermediate Similarity | NPD1535 | Discovery |
0.7063 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD6778 | Approved |
0.7059 | Intermediate Similarity | NPD6779 | Approved |
0.7059 | Intermediate Similarity | NPD6777 | Approved |
0.7059 | Intermediate Similarity | NPD6780 | Approved |
0.7059 | Intermediate Similarity | NPD6782 | Approved |
0.7059 | Intermediate Similarity | NPD6781 | Approved |
0.7059 | Intermediate Similarity | NPD6776 | Approved |
0.7052 | Intermediate Similarity | NPD3787 | Discontinued |
0.7047 | Intermediate Similarity | NPD17 | Approved |
0.7037 | Intermediate Similarity | NPD4109 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD4110 | Phase 3 |
0.7031 | Intermediate Similarity | NPD8151 | Discontinued |
0.7027 | Intermediate Similarity | NPD9545 | Approved |
0.7024 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7022 | Intermediate Similarity | NPD7240 | Approved |
0.702 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7018 | Intermediate Similarity | NPD6971 | Discontinued |
0.7 | Intermediate Similarity | NPD4288 | Approved |
0.6994 | Remote Similarity | NPD2309 | Approved |
0.6993 | Remote Similarity | NPD1470 | Approved |
0.6987 | Remote Similarity | NPD6798 | Discontinued |
0.6987 | Remote Similarity | NPD3764 | Approved |
0.6987 | Remote Similarity | NPD6410 | Clinical (unspecified phase) |
0.6984 | Remote Similarity | NPD6823 | Phase 2 |
0.6968 | Remote Similarity | NPD4908 | Phase 1 |
0.6962 | Remote Similarity | NPD6355 | Discontinued |
PubChem CID   | 3080568 |
ChEMBL   | CHEMBL469424 |
ZINC   |
Molecular Weight:   | 348.08 |
ALogP:   | -0.7131 |
MLogP:   | 2.45 |
XLogP:   | 2.415 |
# Rotatable Bonds:   | 12 |
Polar Surface Area:   | 122.52 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 3 |
# Rings:   | 2 |
# Heavy Atoms:   | 25 |